KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) EBT (2016 - 2025)

Historic EBT for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $703000.0.

  • Biolife Solutions' EBT rose 22758.62% to $703000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 94867.21%. This contributed to the annual value of -$11.4 million for FY2024, which is 3814.63% up from last year.
  • Biolife Solutions' EBT amounted to $703000.0 in Q3 2025, which was up 22758.62% from -$15.7 million recorded in Q2 2025.
  • Biolife Solutions' 5-year EBT high stood at $90.7 million for Q4 2022, and its period low was -$76.6 million during Q2 2022.
  • Over the past 5 years, Biolife Solutions' median EBT value was -$4.9 million (recorded in 2021), while the average stood at -$4.4 million.
  • Over the last 5 years, Biolife Solutions' EBT had its largest YoY gain of 59503.36% in 2022, and its largest YoY loss of 153851.58% in 2022.
  • Over the past 5 years, Biolife Solutions' EBT (Quarter) stood at -$18.3 million in 2021, then surged by 595.03% to $90.7 million in 2022, then tumbled by 87.47% to $11.4 million in 2023, then tumbled by 118.77% to -$2.1 million in 2024, then surged by 132.96% to $703000.0 in 2025.
  • Its EBT stands at $703000.0 for Q3 2025, versus -$15.7 million for Q2 2025 and -$434000.0 for Q1 2025.